SEC Form 4 reporting owner

Sullivan Louis W

Sullivan Louis W has filed 6 Form 4 transactions reported between December 22, 2025 and July 22, 2026, as a reporting owner of UNITED THERAPEUTICS Corp.

Name as filed: SULLIVAN LOUIS W

Open-market buys, 24 mo
None
reported
Open-market sales, 24 mo
$3.0M
2 lines
Companies
1
with Form 4 filings
Latest transaction
Jul 22, 2026
transaction date

Roles and reported holdings

  • UTHRUNITED THERAPEUTICS Corp
    Dec 22, 2025 – Jul 22, 2026

    Reporting owner

    Held indirectly (latest line)0 sh as of Dec 22, 2025 · Form 4

    24 months: $3.0M sold

Transaction history

All 6 reported transactions, newest first. Every row links to the Form 4 on SEC EDGAR.

DateCompanyTypeSharesValueFiling
Jul 22, 2026UTHRGrant or awardCode A · direct2,380—Form 4
Jul 9, 2026UTHROption exerciseCode M · direct650—Form 4
Dec 22, 2025UTHROpen-market saleCode S · indirect4,863$2.5M@ $512.34Form 4
Dec 22, 2025UTHROpen-market saleCode S · indirect1,087$556K@ $511.22Form 4
Dec 22, 2025UTHROption exerciseCode M · indirect2,720$625K@ $229.81Form 4
Dec 22, 2025UTHROption exerciseCode M · indirect3,230$594K@ $183.98Form 4

How this page is built

Every row comes from a Form 4 filed with the SEC, which officers, directors and holders of more than 10% of a company’s stock must file within two business days of a trade. Transactions are grouped by the reporting owner’s name as filed (spacing, capitals and punctuation ignored); two different people filing under an identical name would appear together, and one person filing under two spellings appears on two pages.

Open-market totals count code P purchases and code S sales over the last 24 months. The same trade reported on more than one filing is counted once; when another owner (for example a fund and its general partner) reports the identical trade, they are listed beside it. Holdings are the shares owned after the latest purchase, sale, gift or tax-withholding line, shown separately for direct and indirect ownership; an indirect figure is one holding line, not a total across every trust or entity.

This page describes what was filed with the SEC; it is not investment advice or a recommendation to buy or sell any security.